Vermilion Therapeutics aims to create innovative new drugs from
Japanese science, and aims to innovate new modality and technology
in collaboration with academia science.
Sep. 28, 2022
”2022 Best Paper Award” from Japanese Society of Medical Mycology
Jul. 19, 2022
Research team from Vermilion Therapeutics Inc. and University of Tokyo, has joined Award-Reception of “Cutting-Edge technology” Award
Jun. 09, 2022
Vermilion Therapeutics Inc., University of Tokyo, and Wakayama Medical Univ. has received the “Special Award of Cutting-Edge Technology”
Vermilion Therapeutics Inc. is aiming to research and develop new treatments for Alzheimer’s disease, Cardiac and Kidney Amyloidosis, Corona virus infections (SARS-CoV-2), and Solid tumors and malignant cancer.